Navigation Links
Centaur Animal Health Appoints New President and Chief Executive Officer.

KANSAS CITY, Kan. and PHILADELPHIA, Aug. 27, 2013 /PRNewswire/ -- Centaur Animal Health, is pleased to announce the appointment of Jeffrey Boily as President, CEO, and Director effective September 1, 2013.

Mark Metrokotsas, who has been the CEO, will become Chairman of Centaur's Board of Directors.

Boily brings over 30 years of global life sciences experience in pharmaceuticals, biotechnology, drug delivery and animal health and will be instrumental in accelerating plans toward Centaur becoming a major animal health company. Centaur has established a track record of successful execution on product initiatives and is aggressively looking to in-license additional products.

"I'm delighted to lead Centaur Animal Health as we embark on the next phase of growth," said Boily.

"Jeff's background as an entrepreneurial leader and his experience in fund-raising and partnering with large and small firms is a perfect fit for Centaur," said Mark Metrokotsas, Board Chair for Centaur Animal Health.

Jeffrey Boily is non-executive Chairman of ProteaPex Therapeutics, a firm researching and developing innovative animal health therapeutics. Most recently he was President and CEO of the Center for Animal Health Innovation which focused on identifying and funding breakthrough technologies. Previous to this, he was CEO of BioWizard, a VC funded research and information firm for biomedical scientists. He gained large company executive experience at Abbott, Rogers and Wyeth including Fort Dodge Animal Health. He holds an M.B.A. from the John Molson School of Business, Concordia U., Montreal and a B.S. in biology from the U. of Ottawa. He also serves on the Board of Directors of various healthcare companies.

About Centaur Animal Health

Centaur Animal Health is focused on developing innovative diagnostics, pharmaceuticals and nutraceuticals that address significant therapeutic needs for companion and production animals. Centaur licenses patent-protected technologies acquired from animal health or human pharmaceutical and biotechnology companies. Contract manufacturing is available in their FDA certified plant. For more information, please visit

For Media:
Jeffrey Boily
Centaur Animal Health
O: (484) 619-3685
Web Site:

SOURCE Centaur Animal Health
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Inovio Pharmaceuticals Malaria DNA Vaccine Demonstrates Robust Immune Responses in Animal Models
2. Henry Schein to Open NASDAQ Stock Market to Celebrate Rebranding of U.S. Animal Health Business
3. Revalesio Presents Data Showing RNS60 Alters Disease Progression in Animal Model of Alzheimers Disease Through the PI3k-Akt Pathway
4. Synthetically Optimized HIF-1 Alpha DNA Delivered with Inovios Electroporation Technology Provides Significant Therapeutic Effects for Peripheral Arterial Disease in Animal Model
5. Inovios Universal H7N9 DNA Vaccine Generates First Protective Antibody Responses Against Virulent H7N9 Virus in 100% of Vaccinated Animals
6. Masimo Signs Far-Reaching Pulse Oximetry Distribution Deal with Butler Schein Animal Health
7. Small Animal Imaging (In Vivo) Market - By systems and reagents - Competitive Analysis & Global Forecasts to 2017
8. McCord Animal Health Introduces Board of Advisors
9. Peter Dinklage Joins Cruelty Free International to Call for US ban on Animal Tests for Cosmetics
10. Star Scientific and Rock Creek Pharmaceuticals Report on the Beneficial Nutritional Effects of Anatabine in an Animal Model of Ulcerative Colitis
11. WuXi PharmaTech Receives Letter from AAALAC Commending Animal Care at Suzhou Toxicology Facility as "Exemplary"
Post Your Comments:
(Date:11/30/2015)... 30, 2015  QT Vascular Ltd., together with its ... its subsidiaries, TriReme Medical LLC and Quattro Vascular Pte. ... the design, assembly and distribution of advanced therapeutic solutions ... pleased to announce that a three-judge panel of ... for the Federal Circuit ("Federal Circuit") has unanimously granted ...
(Date:11/30/2015)... CITY, Calif. , Nov. 30, 2015 Nevro ... that is providing innovative evidence-based solutions for the treatment of ... Board (PTAB) at the U.S. Patent and Trademark Office (USPTO) ... of U.S. Patent No. 8,359,102 (the ,102 patent).  ... 2015, a unit of Boston Scientific Corporation filed two petitions ...
(Date:11/30/2015)... Calif. , Nov. 30, 2015 /PRNewswire/ ... today that Matt Hogan , Chief ... Oppenheimer Healthcare Conference on Tuesday, December 8 ... is being held at the Westin Grand ... also be available for one-on-one meetings at ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... In an effort ... the Word of Life Christian Church of Flint, MI, hosted a family-oriented evening ... 1.25 ton pile of candy dubbed “Candy Mountain”. , A Forever Recovery, a ...
(Date:11/30/2015)... ... 2015 , ... On Saturday, October 24th, 2015, at the Mill Race Park ... a 5K walk known as “Making Strides Against Breast Cancer”. Patients and staff members ... located in Battle Creek, joined in for this campaign that sought to raise donations ...
(Date:11/30/2015)... ... November 30, 2015 , ... In an effort to ... to access life-saving information provided directly from top experts in mesothelioma, in 2016 ... conferences in three major cities: Houston, San Francisco, and Chicago. , “For ...
(Date:11/30/2015)... ... November 30, 2015 , ... The presidential race normally deals with ... why is it a national news story when Donald Trump makes disparaging remarks about ... appearances count more than anyone wants to admit when it comes to how people ...
(Date:11/30/2015)... ... November 30, 2015 , ... During the week of ... raise funds for its research, education, support, and advocacy efforts. The campaign is ... , The Mesothelioma Applied Research Foundation, which also goes by Meso Foundation, holds ...
Breaking Medicine News(10 mins):